Unfortunately, an error has occurred. Here you will find a list of possible results.
error
Darmkrebs – Immer noch ein Tabuthema
The fear of being diagnosed with bowel cancer and the feeling of powerlessness mean that far too little preventive care is still being taken. This is despite the fact that around 1.9 million people are diagnosed with colorectal cancer every year, more than 60,000 of them in Germany. With more than 24,000 deaths in Germany alone, colorectal carcinoma, i.e. cancer of the large intestine or rectum, is also the third most frequent cancer-related cause of death. For this reason, everyone should concern themselves with this topic - because bowel cancer screening can save lives!
But what is bowel cancer and how does the disease develop? What are the symptoms and signs? Do some people get bowel cancer more often than others? What can be done to prevent bowel cancer or increase the chances of curing it?
Early detection of colorectal cancer: a key to saving lives
Discover the secrets of colorectal cancer screening. Find out why timely screening is so important, how to prevent the development of cancer and learn about the recommended screening methods. Read the article now and learn more about expert knowledge and tips to optimise your health.
PreventID® TB Combo
PreventID® TB Combo is an immunological qualitative rapid test for the determination of human antibodies against the three tuberculosis pathogens M. tuberculosis, M. bovis and M. africanum in whole blood, serum or plasma (heparin). Several immunoglobulin isotypes are detected (IgG, IgM, IgA, etc.). The detection of these antibodies is used to diagnose tuberculosis (TB).
PreventID® Syphilis
PreventID® Syphilis uses a dual antigen combination of syphilis antigen-coated particles and syphilis antigen immobilized on the membrane to qualitatively and selectively detect TP antibodies (IgG and IgM) in whole blood, serum or plasma.
The test result can be read 5 minutes after application of the sample.